603301.SHG Zhende Medical Co Ltd
- Market cap
- CNY 22.0B
- P/E
- 71.1x
- P/B
- 3.77x
- ROE
- 5.5%
- Dividend yield
- 0.92%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 603301.SHG undervalued?
Graham numberThe Graham number of Zhende Medical Co Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhende Medical Co Ltd fundamental analysis
No fundamental analysis for Zhende Medical Co Ltd yet.
Zhende Medical Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhende Medical Co Ltd
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers a gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical …
Full company profileZhende Medical Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhende Medical Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.03B | 1.31B | 1.43B | 1.87B | 10.4B | 5.09B | 6.14B | 4.13B | 4.26B | 4.33B | 4.68B |
| Gross Profit | 323M | 382M | 440M | 592M | 4.83B | 1.74B | 2.07B | 1.28B | 1.41B | 1.47B | 1.62B |
| Operating Income | 79.2M | 148M | 153M | 200M | 3.54B | 822M | 813M | 226M | 492M | 388M | 456M |
| EBITDA | 174M | 230M | 235M | 295M | 3.63B | 979M | 1.02B | 493M | 744M | 654M | 401M |
| Net Income | 82.8M | 122M | 130M | 157M | 2.55B | 596M | 680M | 198M | 385M | 261M | 316M |
| EPS | 0.57 | 0.83 | 0.72 | 0.80 | 13 | 2.63 | 2.87 | 0.74 | 1.45 | 0.98 | 1.20 |
| Balance Sheet | |||||||||||
| Total Assets | 1.13B | 1.29B | 1.85B | 2.67B | 6.40B | 6.42B | 7.90B | 7.27B | 7.58B | 8.40B | 8.50B |
| Total Liabilities | 690M | 734M | 725M | 1.27B | 1.93B | 1.98B | 2.14B | 1.66B | 1.68B | 2.44B | 2.49B |
| Shareholders' Equity | 437M | 559M | 1.12B | 1.36B | 4.18B | 4.07B | 5.54B | 5.37B | 5.64B | 5.69B | 5.74B |
| Cash & Short-term Investments | 63.5M | 114M | 302M | 687M | 2.01B | 1.36B | 2.17B | 1.21B | 828M | 825M | 838M |
| Total Debt | 390M | 410M | 366M | 715M | 453M | 848M | 564M | 460M | 551M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 139M | 182M | 20.2M | 198M | 3.12B | 818M | 1.25B | 452M | 461M | 538M | - |
| Capital Expenditure | 159M | 144M | 227M | 274M | 1.09B | 695M | 754M | 599M | 770M | 550M | 289M |
| Free Cash Flow | -20.7M | 37.9M | -206M | -76.0M | 2.03B | 122M | 492M | -147M | -309M | -11.7M | -17.4M |
| Ratios | |||||||||||
| ROE | 18.9% | 21.8% | 11.6% | 11.5% | 61.0% | 14.7% | 12.3% | 3.7% | 6.8% | 4.6% | 5.5% |
| ROA | 7.3% | 9.4% | 7.0% | 5.9% | 39.8% | 9.3% | 8.6% | 2.7% | 5.1% | 3.1% | 3.7% |
| Net Profit Margin | 8.0% | 9.3% | 9.1% | 8.4% | 24.5% | 11.7% | 11.1% | 4.8% | 9.0% | 6.0% | 6.8% |
| Debt to Equity | 0.89x | 0.73x | 0.33x | 0.53x | 0.11x | 0.21x | 0.10x | 0.09x | 0.10x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Zhende Medical Co Ltd dividends
- Dividend yield
- 0.92%
- Forward dividend
- 0.30 CNY
- Payout ratio
- 77.3%
- Ex-dividend date
- Jun 18, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 201M | 0.76 | 77.3% |
| 2024 | CNY 159M | 0.60 | 41.4% |
| 2023 | CNY 424M | 1.58 | 213.6% |
| 2022 | CNY 164M | 0.69 | 24.2% |
| 2021 | CNY 523M | 2.31 | 87.7% |
| 2020 | CNY 60.2M | 0.30 | 2.4% |
| 2019 | CNY 35.0M | 0.18 | 22.3% |
| 2018 | CNY 21.0M | 0.12 | 16.1% |
| 2017 | CNY 21.4M | 0.14 | 17.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.4:1 on Jun 8, 2020.
Who owns Zhende Medical Co Ltd
- Insiders 67.44%
- Institutions 3.21%
- Public & others 29.35%
- Shares outstanding 264M
- Free float 100M
Zhende Medical Co Ltd company profile
- Company name
- Zhende Medical Co Ltd
- Ticker
- 603301.SHG
- ISIN
- CNE100003J31
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 7,909
- Fiscal year end
- December
- Address
- No. 55, Xiangji Road, Shaoxing, China, 312035
- Phone
- 86 575 8808 0366
- Website
- zhende.com
About Zhende Medical Co Ltd
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers a gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical gown, scrub suit, warm-up jacket, surgical headwear, and isolation gown; surgical drape; standard surgical pack and custom procedure pack; disposable sterile; equipment cover; OP Tape, hand towel, and fluid collection pouch; latex surgical glove; CSR wrap; infection control and protection products; basic nursing care products; pressure therapy and immobilization products; stoma and modern wound care products, and respiratory anesthesia consumable; and warming blanket system. In addition, the company offers an isolation gown, surgical cap, shoe cover, medical mask, and particular respirator; compression bandage and compression stocking; wound care products; pre-filled flush syringes; and ostomy and accessories. Further, it provides respiratory health, home cleaning, IP collaboration, nasal care, protective gear and assistive devices, and personal beauty products. Zhende Medical Co., Ltd. was incorporated in 1994 and is headquartered in Shaoxing, China.
Zhende Medical Co Ltd management
8- Mr. Jianguo LuChairman of the Board & GM · born 1970
- Ms. Haiping JinCFO & Financial Director · born 1976
- Mr. Zhendong ShenDirector & Deputy GM · born 1974
- Mr. Dasheng XuDeputy GM & Director · born 1974
- Mr. Baohai JiSecretary of the Board of Directors · born 1980
- Mr. Junwu HuDeputy General Manager · born 1977
- Mr. Jiangtao LongDeputy General Manager · born 1976
- Shuyan MaHead of Accounting & Accounting Supervisor